Iradimed Corporation (NASDAQ: IRMD), known for its MRI-compatible medical devices and maintaining a robust 76.91% gross profit margin, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MRidium® 3870 IV Infusion Pump System. This latest innovation from Iradimed is designed to enhance patient safety and improve workflow efficiency during MRI procedures.
The MRidium® 3870, which builds on the company’s first-generation device introduced in 2005, is the only non-magnetic MRI infusion pump device on the market, according to the company’s statement. The system features a non-magnetic ultrasonic pump motor and non-ferrous components, which are essential for safe operation within high-magnetic-field environments such as MRI rooms. The company’s focus on innovative medical devices has contributed to its impressive 11.04% revenue growth over the last twelve months.
This next-generation system also introduces a user-friendly graphical touchscreen interface and advanced safety features. The 3870 can be used independently or linked with additional pumps to form a four-channel system, making it versatile for various critical care situations. Moreover, it includes a modern drug library solution that supports multiple patient care area drug listings.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.